Fig. 2From: Efficacy and safety of mineralocorticoid receptor antagonists for patients with heart failure and diabetes mellitus: a systematic review and meta-analysisForest plot of the comparison of treatment with MRAs versus without MRAs on all-cause mortality. Three of included studies evaluated the effect of MRAs on all-cause mortality. The mortality was 19 % in MRA groups compared with 23 % in control groups. The studies suggested that MRAs-based regimens reduced the risk of all-cause mortality in comparison to regimens without MRAsBack to article page